The U.S. Food and Drug Administration (FDA) indicated it didn’t expect major shortages in drug manufacturing after a tornado hit a Pfizer pharmaceutical plant in North Carolina on Wednesday.
“We do not expect there to be any immediate significant impacts on supply given the products are currently at hospitals and in the distribution system,” FDA Commissioner Robert Califf said Friday.